| Frazier Life Sciences Public Fund, L.P. |
4.2% |
1.38M |
0 |
1.38M |
/s/ Steve R. Bailey |
By Steve R. Bailey, CFO of FHMLSP, L.L.C., GP of FHMLSP, L.P., GP of Frazier Life Sciences Public Fund, L.P. |
|
| FHMLSP, L.P. |
4.2% |
1.38M |
0 |
1.38M |
/s/ Steve R. Bailey |
By Steve R. Bailey, CFO of FHMLSP, L.L.C., GP of FHMLSP, L.P. |
|
| FHMLSP, L.L.C. |
4.2% |
1.38M |
0 |
1.38M |
/s/ Steve R. Bailey |
By Steve R. Bailey, CFO of FHMLSP, L.L.C. |
|
| Frazier Life Sciences X, L.P. |
0% |
9.49K |
0 |
9.49K |
/s/ Steve R. Bailey |
By Steve R. Bailey, CFO of FHMLS X, L.L.C., GP of FHMLS X, L.P., GP of Frazier Life Sciences X, L.P. |
|
| FHMLS X, L.P. |
0% |
9.49K |
0 |
9.49K |
/s/ Steve R. Bailey |
By Steve R. Bailey, CFO of FHMLS X, L.L.C., GP of FHMLS X, L.P. |
|
| FHMLS X, L.L.C. |
0% |
9.49K |
0 |
9.49K |
/s/ Steve R. Bailey |
By Steve R. Bailey, CFO of FHMLS X, L.L.C. |
|
| Frazier Life Sciences XI, L.P. |
0.1% |
19.1K |
0 |
19.1K |
/s/ Steve R. Bailey |
By Steve R. Bailey, CFO of FHMLS XI, L.L.C., GP of FHMLS XI, L.P., GP of Frazier Life Sciences XI, L.P. |
|
| FHMLS XI, L.P. |
0.1% |
19.1K |
0 |
19.1K |
/s/ Steve R. Bailey |
By Steve R. Bailey, CFO of FHMLS XI, L.L.C., GP of FHMLS XI, L.P. |
|
| FHMLS XI, L.L.C. |
0.1% |
19.1K |
0 |
19.1K |
/s/ Steve R. Bailey |
By Steve R. Bailey, CFO of FHMLS XI, L.L.C. |
|
| James N. Topper |
0% |
9.49K |
0 |
9.49K |
/s/ Steve R. Bailey |
By Steve R. Bailey, Attorney-in-Fact for James N. Topper, pursuant to a Power of Attorney, a copy of which was filed with the SEC on July 31, 2017 |
|
| Patrick J. Heron |
0% |
9.49K |
0 |
9.49K |
/s/ Steve R. Bailey |
By Steve R. Bailey, Attorney-in-Fact for Patrick J. Heron, pursuant to a Power of Attorney, a copy of which was filed with the SEC on July 31, 2017 |
|